This event has already occurred.
Sarah Lisanby, MD
Translational Development of Noninvasive Brain Stimulation Treatments for Depression
Chair, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina
2 Riverside Circle, Roanoke, VA 24016
About the Speaker:
Sarah "Holly" Lisanby, MD is the chair of the Department of Psychiatry and Behavioral Sciences at Duke University School of Medicine.
Dr. Lisanby earned undergraduate degrees in mathematics and psychology at Duke University, where she also received her medical degree and did her residency in psychiatry. She did postdoctoral research training at Columbia University in affective disorders and geriatric psychiatry. She later joined the faculty at Columbia University, where she served as chief of the Brain Stimulation and Therapeutic Modulation Division.
An expert in translational research in the field of brain stimulation, Dr. Lisanby has been recognized for her leading role in pioneering a novel depression treatment called magnetic seizure therapy, which her team took through the steps from bench to bedside and is now in multicenter, international collaborative trials. Dr. Lisanby has authored or coauthored more than 150 articles, abstracts, chapters, books, reviews, and editorials on transcranial magnetic stimulation, electroconvulsive therapy, depression, and related topics.
Dr. Lisanby is the former president of two leading international professional organizations on brain stimulation—the Association for Convulsive Therapy (now the International Society for ECT and Neurostimulation) and the International Society on Transcranial Stimulation. She has received more than 35 honors and awards, including the Max Hamilton Memorial Prize of the Collegium Internationale Neuro-Psychoharmacologicum and both the Distinguished Investigator Award and the Gerald L. Klerman Award from the National Alliance for Research on Schizophrenia and Depression.